Covid-19 is a recently emerging infectious disease with a very large impact on health care world-wide. The disease is still poorly described. It is an urgent need for better clinical characteristics. A prospective, quality register is therefore established for increasing the knowledge about the disease, the covid patients and the prognosis.
All patient hospitalized at Oslo University Hospital, Ullevål, is prospectively registered in
the approved quality register. Background, clinical and paraclinical data is harvested and
registered, as well as treatment and mortality.
Inclusion Criteria:
- Confirmed covid-19
- hospitalized
Exclusion Criteria:
- None
Oslo University Hospital
Oslo, Norway
Investigator: Aleksander Holten, PhD
Aleksander Holten, MD
+4799275784
aleksander.holten@gmail.com
Kristian Tonby, MD
+4741550565
kritonby@ous-hf.no
Kristian Tonby, MD, Study Director
Oslo University Hospital